No connection

Search Results

CCM vs ZJYL

CCM
Concord Medical Services Holdings Limited
BEARISH
Price
$4.00
Market Cap
$17.4M
Sector
Healthcare
AI Confidence
95%
ZJYL
Jin Medical International Ltd.
BEARISH
Price
$2.15
Market Cap
$16.9M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
CCM
--
ZJYL
10.78
Forward P/E
CCM
-26.67
ZJYL
--
P/B Ratio
CCM
-0.05
ZJYL
0.57
P/S Ratio
CCM
0.05
ZJYL
0.82
EV/EBITDA
CCM
-22.79
ZJYL
7.14

Profitability

Gross Margin
CCM
-11.44%
ZJYL
30.18%
Operating Margin
CCM
-72.1%
ZJYL
9.83%
Profit Margin
CCM
-44.6%
ZJYL
5.76%
ROE
CCM
-29.03%
ZJYL
4.75%
ROA
CCM
-4.48%
ZJYL
0.77%

Growth

Revenue Growth
CCM
-8.3%
ZJYL
-16.5%
Earnings Growth
CCM
--
ZJYL
-32.0%

Financial Health

Debt/Equity
CCM
2.22
ZJYL
0.64
Current Ratio
CCM
0.42
ZJYL
1.85
Quick Ratio
CCM
0.1
ZJYL
1.53

Dividends

Dividend Yield
CCM
--
ZJYL
--
Payout Ratio
CCM
0.0%
ZJYL
0.0%

AI Verdict

CCM BEARISH

CCM exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a critical liquidity crisis. The company suffers from negative gross margins (-11.44%), meaning it loses money on every unit of service provided before operating expenses are even considered. With a Price-to-Book ratio of -0.05, the company has negative shareholder equity, and a Quick Ratio of 0.10 indicates an inability to meet short-term obligations. Combined with declining revenue (-8.30% YoY) and a 5-year price collapse of 89%, the fundamental outlook is highly precarious.

Strengths
Extremely low Price-to-Sales ratio (0.05)
Recent short-term price recovery (+9.6% over 1 month)
Positive Q/Q EPS growth (+60.4%) though still negative in absolute terms
Risks
Negative Gross Margins indicating a fundamentally broken business model
Severe liquidity risk with a Current Ratio of 0.42 and Quick Ratio of 0.10
Negative Book Value (Price/Book -0.05) suggesting insolvency
ZJYL BEARISH

ZJYL presents a classic 'value trap' scenario, characterized by a stable Piotroski F-Score of 6/9 and a price significantly below its Graham Number ($4.13), yet plagued by severe fundamental decay. While the company maintains a healthy balance sheet with a current ratio of 1.85 and low debt/equity (0.64), it is suffering from catastrophic growth contraction, with revenue down 16.5% and earnings down 32% YoY. The massive 87.7% decline in share price over the last year reflects a market that has completely lost confidence in the company's growth trajectory. Despite trading at a deep discount to book value (P/B 0.57), the lack of positive catalysts and bearish technical trend outweigh the valuation appeal.

Strengths
Trading significantly below book value (P/B 0.57)
Stable financial health indicated by Piotroski F-Score of 6/9
Strong liquidity position with a Current Ratio of 1.85
Risks
Severe revenue contraction (-16.5% YoY)
Sharp decline in earnings growth (-32% YoY)
Catastrophic 1-year price performance (-87.7%)

Compare Another Pair

CCM vs ZJYL: Head-to-Head Comparison

This page compares Concord Medical Services Holdings Limited (CCM) and Jin Medical International Ltd. (ZJYL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile